News for Healthier Living

InterShunt Enrolls First Patient in New Heart Failure Study

InterShunt Technologies, Inc., a medical device company focused on developing minimally invasive treatments for heart failure, has officially kicked off its latest clinical study, the EASE HF2 Early Feasibility Study, which is evaluating a device designed to reduce heart failure symptoms and improve quality of life.

June 30, 2025


June 30 2025

June 29 2025

June 28 2025

June 27 2025

June 26 2025

June 25 2025

June 24 2025

June 23 2025

June 22 2025

June 21 2025

June 20 2025

June 19 2025

June 18 2025

June 17 2025